Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;27(8):526-536.
doi: 10.1111/gtc.12971. Epub 2022 Jun 23.

Genetic inhibition of collapsin response mediator protein-2 phosphorylation ameliorates retinal ganglion cell death in normal-tension glaucoma models

Affiliations
Free article

Genetic inhibition of collapsin response mediator protein-2 phosphorylation ameliorates retinal ganglion cell death in normal-tension glaucoma models

Musukha Mala Brahma et al. Genes Cells. 2022 Aug.
Free article

Abstract

Glaucoma is a neurodegenerative disorder caused by the death of retinal ganglion cells (RGCs). Elevated intraocular pressure (IOP) is a cause of glaucoma. However, glaucoma often develops with normal IOP and is known as normal-tension glaucoma (NTG). Glutamate neurotoxicity is considered as one of the significant causes of NTG, resulting in excessive stimulation of retinal neurons via the N-methyl-D-aspartate (NMDA) receptors. The present study examined the phosphorylation of collapsin response mediator protein-2 (CRMP2), a protein that is abundantly expressed in neurons and involved in their development. In two mouse models, NMDA-injection and glutamate/aspartate transporter (GLAST) mutant, CRMP2 phosphorylation at the cyclin-dependent kinase-5 (Cdk5) site was elevated in RGCs. We confirmed that the decrease in the number of RGCs and thickness of the inner retinal layer (IRL) could be suppressed after NMDA administration in CRMP2KI/KI mice with genetically inhibited CRMP2 phosphorylation. Next, we investigated GLAST heterozygotes (GLAST+/-) with CRMP2KI/KI (GLAST+/-;CRMP2KI/KI) and GLAST knockout (GLAST-/-) mice with CRMP2KI/KI (GLAST-/-;CRMP2KI/KI) mice and compared them with GLAST+/- and GLAST-/- mice. pCRMP2 (S522) inhibition significantly reduced RGC loss and IRL thinning. These results suggest that the inhibition of CRMP2 phosphorylation could be a novel strategy for treating NTG.

Keywords: CRMP; GLAST; NMDA; inner retinal layer; mouse; normal tension glaucoma; phosphorylation; retinal ganglion cell.

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. Agarwal, R., Gupta, S. K., Agarwal, P., Saxena, R., & Agrawal, S. (2009). Current concepts in the pathophysiology of glaucoma. Indian Journal of Ophthalmology, 57, 257-266. https://doi.org/10.4103/0301-4738.5304
    1. Arimura, N., Kimura, T., Nakamuta, S., Taya, S., Funahashi, Y., Hattori, A., Shimada, A., Ménager, C., Kawabata, S., Fujii, K., Iwamatsu, A., Segal, R. A., Fukuda, M., & Kaibuchi, K. (2009). Anterograde transport of TrkB in axons is mediated by direct interaction with Slp1 and Rab27. Developmental Cell, 16(5), 675-686. https://doi.org/10.1016/j.devcel.2009.03.005
    1. Barnstable, C. J. (1993). Glutamate and GABA in retinal circuitry. Current Opinion in Neurobiology, 3(4), 520-525. https://doi.org/10.1016/0959-4388(93)90050-9
    1. Baudry, M., & Bi, X. (2016). Calpain-1 and calpain-2: The yin and yang of synaptic plasticity and neurodegeneration. Trends in Neurosciences, 39(4), 235-245. https://doi.org/10.1016/j.tins.2016.01.007
    1. Behar, T. N., Scott, C. A., Greene, C. L., Wen, X., Smith, S. V., Maric, D., Liu, Q. Y., Colton, C. A., & Barker, J. L. (1999). Glutamate acting at NMDA receptors stimulates embryonic cortical neuronal migration. The Journal of Neuroscience, 19, 4449-4461. https://doi.org/10.1523/JNEUROSCI.19-11-04449

Substances

LinkOut - more resources